UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Rosenberg Matthew Hamilton

Rosenberg Matthew Hamilton boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,366 shares of the healthcare conglomerate’s stock after buying an additional 46 shares during the period. Rosenberg Matthew Hamilton’s holdings in UnitedHealth Group were worth $716,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of UNH. Brighton Jones LLC raised its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG increased its stake in shares of UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after acquiring an additional 9,872 shares during the period. Victory Capital Management Inc. lifted its position in UnitedHealth Group by 3.8% in the fourth quarter. Victory Capital Management Inc. now owns 627,739 shares of the healthcare conglomerate’s stock valued at $317,548,000 after purchasing an additional 22,788 shares during the period. Finally, Carrera Capital Advisors raised its stake in shares of UnitedHealth Group by 9.3% during the 4th quarter. Carrera Capital Advisors now owns 553 shares of the healthcare conglomerate’s stock worth $280,000 after buying an additional 47 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the firm’s stock in a transaction dated Friday, May 16th. The stock was acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer owned 679,493 shares of the company’s stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO John F. Rex purchased 17,175 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the acquisition, the chief financial officer directly owned 203,796 shares of the company’s stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last three months. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $307.69 on Thursday. The stock has a fifty day moving average price of $329.50 and a 200 day moving average price of $450.21. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The firm has a market capitalization of $279.12 billion, a P/E ratio of 12.88, a PEG ratio of 1.55 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the previous year, the company earned $6.91 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.87%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Analysts Set New Price Targets

Several research firms have issued reports on UNH. Truist Financial reiterated a “buy” rating and issued a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Royal Bank Of Canada lowered their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research report on Friday, May 16th. Mizuho decreased their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Deutsche Bank Aktiengesellschaft reduced their price objective on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a report on Wednesday, May 14th. Finally, Erste Group Bank cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.